Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 | |||||
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | Missense mutations of the BRAF gene in human lung adenocarcinoma. | 12460919 | 2002 | |||||
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | Mutations of the BRAF gene in human cancer. | 12068308 | 2002 | |||||
Carcinoma of lung
|
0.800 | GeneticVariation | UNIPROT | Missense mutations of the BRAF gene in human lung adenocarcinoma. | 12460919 | 2002 | |||||
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | Genetic predictors of MEK dependence in non-small cell lung cancer. | 19010912 | 2008 | |||||
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. | 19238210 | 2009 | |||||
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. | 21483012 | 2011 | |||||
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib. | 22649091 | 2012 | |||||
Carcinoma of lung
|
0.800 | GeneticVariation | UNIPROT | Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. | 23562183 | 2013 | |||||
Carcinoma of lung
|
0.800 | GeneticVariation | UNIPROT | Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group. | 23667368 | 2013 | |||||
Carcinoma of lung
|
0.800 | CausalMutation | CLINVAR | Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. | 23833300 | 2013 | |||||
Carcinoma of lung
|
0.800 | GeneticVariation | UNIPROT | Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline. | 25311215 | 2014 | |||||
Carcinoma of lung
|
0.800 | GeneticVariation | UNIPROT | Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group. | 24627688 | 2014 | |||||
Carcinoma of lung
|
0.800 | GeneticVariation | UNIPROT | Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design. | 24846033 | 2014 |